药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Zinc
Mibolerone
The risk or severity of edema formation can be increased when Mibolerone is combined with Hydrocortisone acetate.
Zinc
Dienogest
The risk or severity of edema formation can be increased when Dienogest is combined with Hydrocortisone acetate.
Zinc
Formestane
The risk or severity of edema formation can be increased when Formestane is combined with Hydrocortisone acetate.
Zinc
Nandrolone decanoate
The risk or severity of edema formation can be increased when Nandrolone decanoate is combined with Hydrocortisone acetate.
Zinc
Testosterone succinate
The risk or severity of edema formation can be increased when Testosterone succinate is combined with Hydrocortisone acetate.
Zinc
Epitestosterone
The risk or severity of edema formation can be increased when Epitestosterone is combined with Hydrocortisone acetate.
Zinc
Fluasterone
The risk or severity of edema formation can be increased when Fluasterone is combined with Hydrocortisone acetate.
Zinc
Trestolone
The risk or severity of edema formation can be increased when Trestolone is combined with Hydrocortisone acetate.
Zinc
16-Bromoepiandrosterone
The risk or severity of edema formation can be increased when 16-Bromoepiandrosterone is combined with Hydrocortisone acetate.
Zinc
Phenylacetic acid
The therapeutic efficacy of Phenylacetic acid can be decreased when used in combination with Hydrocortisone acetate.
Zinc
Glycerol phenylbutyrate
The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Hydrocortisone acetate.
Zinc
Phenylbutyric acid
The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Hydrocortisone acetate.
Zinc
Alcuronium
The risk or severity of myopathy and weakness can be increased when Alcuronium is combined with Hydrocortisone acetate.
Zinc
Gallamine
The risk or severity of myopathy and weakness can be increased when Gallamine is combined with Hydrocortisone acetate.
Zinc
Atracurium
The risk or severity of myopathy and weakness can be increased when Atracurium is combined with Hydrocortisone acetate.
Zinc
Neosaxitoxin
The risk or severity of myopathy and weakness can be increased when Neosaxitoxin is combined with Hydrocortisone acetate.
Zinc
Pyrantel
The risk or severity of myopathy and weakness can be increased when Pyrantel is combined with Hydrocortisone acetate.
Zinc
Rapacuronium
The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Hydrocortisone acetate.
Zinc
Capsaicin
The therapeutic efficacy of Capsaicin can be decreased when used in combination with Hydrocortisone acetate.
Zinc
Methylphosphinic Acid
The therapeutic efficacy of Methylphosphinic Acid can be decreased when used in combination with Hydrocortisone acetate.